Galderma Achieves FDA Approval of AKLIEF® (trifarotene) Case Study Galderma Achieves FDA Approval of AKLIEF® (trifarotene) In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…CertaraNovember 9, 2020
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal CertaraOctober 28, 2020
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted Publication Clinical trials of disease stages in COVID 19: complicated and often misinterpreted As of July 28, 2020, 1840 clinical trials were registered globally, with 1001 clinical trials…CertaraAugust 22, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 Publication Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…CertaraAugust 22, 2020
Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Publication Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…CertaraJuly 26, 2020
The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development Blog The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development 3 key tips to set your pediatric program up for success with the RACE for…CertaraJuly 14, 2020
Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Publication Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…CertaraJuly 14, 2020
Local Therapies for the Global COVID-19 Pandemic Blog Local Therapies for the Global COVID-19 Pandemic Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…CertaraMay 29, 2020
Applying decision analysis to drug development for COVID-19 & future pandemics Blog Applying decision analysis to drug development for COVID-19 & future pandemics This blog discusses how decision analysis approaches can help drug developers to better decisions under…CertaraApril 30, 2020
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? On-Demand Webinar The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? This webinar will explain how pricing has evolved for the rare disease drug market and…CertaraFebruary 19, 2020